INSMED INC Operating Expenses
INSMED INC (INSM) reported Operating Expenses of $83.98 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2018-10-30
- INSMED INC operating expenses for the quarter ending 2018-09-30 was $83.98M, a 90.51% increase year-over-year.
- INSMED INC operating expenses for the quarter ending 2018-06-30 was $72.88M, a 67.49% increase year-over-year.
- INSMED INC operating expenses for the quarter ending 2018-03-31 was $62.75M, a 74.46% increase year-over-year.
- INSMED INC operating expenses for the quarter ending 2017-12-31 was $65.35M, a 2.53% decline year-over-year.
- INSMED INC operating expenses for fiscal 2017 was $188.92M, a 8.95% increase from fiscal 2016.
- INSMED INC operating expenses for fiscal 2016 was $173.40M, a 47.58% increase from fiscal 2015.
- INSMED INC operating expenses for fiscal 2015 was $117.49M, a 34.49% increase from fiscal 2014.
- INSMED INC operating expenses for fiscal 2014 was $87.36M, a 31.35% increase from fiscal 2013.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2018-09-30 | $83.98M 10-Q · filed 2018-10-30 | $156.87M derived: sum of 2 quarters · filed 2018-10-30 | $219.62M 10-Q · filed 2018-10-30 | $284.97M derived: sum of 4 quarters · filed 2018-10-30 |
| 2018-06-30 | $72.88M 10-Q · filed 2018-08-02 | $135.63M 10-Q · filed 2018-08-02 | $200.99M derived: sum of 3 quarters · filed 2018-08-02 | $245.07M derived: sum of 4 quarters · filed 2018-10-30 |
| 2018-03-31 | $62.75M 10-Q · filed 2018-05-02 | $128.10M derived: sum of 2 quarters · filed 2018-05-02 | $172.19M derived: sum of 3 quarters · filed 2018-10-30 | $215.70M derived: sum of 4 quarters · filed 2018-10-30 |
| 2017-12-31 | $65.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $109.44M derived: sum of 2 quarters · filed 2018-10-30 | $152.95M derived: sum of 3 quarters · filed 2018-10-30 | $188.92M 10-K · filed 2018-02-23 |
| 2017-09-30 | $44.08M 10-Q · filed 2018-10-30 | $87.60M derived: sum of 2 quarters · filed 2018-10-30 | $123.57M 10-Q · filed 2018-10-30 | $190.62M derived: sum of 4 quarters · filed 2018-10-30 |
| 2017-06-30 | $43.52M 10-Q · filed 2018-08-02 | $79.48M 10-Q · filed 2018-08-02 | $146.53M derived: sum of 3 quarters · filed 2018-08-02 | $183.68M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $35.97M 10-Q · filed 2018-05-02 | $103.02M derived: sum of 2 quarters · filed 2018-05-02 | $140.17M derived: sum of 3 quarters · filed 2018-05-02 | $176.30M derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | $67.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $104.20M derived: sum of 2 quarters · filed 2018-02-23 | $140.33M derived: sum of 3 quarters · filed 2018-02-23 | $173.40M 10-K · filed 2018-02-23 |
| 2016-09-30 | $37.15M 10-Q · filed 2017-11-02 | $73.28M derived: sum of 2 quarters · filed 2017-11-02 | $106.35M 10-Q · filed 2017-11-02 | $138.94M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $36.13M 10-Q · filed 2017-08-03 | $69.20M 10-Q · filed 2017-08-03 | $101.79M derived: sum of 3 quarters · filed 2018-02-23 | $132.03M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $33.07M 10-Q · filed 2017-05-03 | $65.66M derived: sum of 2 quarters · filed 2018-02-23 | $95.90M derived: sum of 3 quarters · filed 2018-02-23 | $123.85M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $32.59M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $62.84M derived: sum of 2 quarters · filed 2018-02-23 | $90.79M derived: sum of 3 quarters · filed 2018-02-23 | $117.49M 10-K · filed 2018-02-23 |
| 2015-09-30 | $30.25M 10-Q · filed 2016-11-03 | $58.20M derived: sum of 2 quarters · filed 2016-11-03 | $84.90M 10-Q · filed 2016-11-03 | $107.97M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $27.95M 10-Q · filed 2016-08-04 | $54.66M 10-Q · filed 2016-08-04 | $77.72M derived: sum of 3 quarters · filed 2017-02-23 | $101.13M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $26.71M 10-Q · filed 2016-05-05 | $49.77M derived: sum of 2 quarters · filed 2017-02-23 | $73.18M derived: sum of 3 quarters · filed 2017-02-23 | $95.99M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $23.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $46.47M derived: sum of 2 quarters · filed 2017-02-23 | $69.29M derived: sum of 3 quarters · filed 2017-02-23 | $87.36M 10-K · filed 2017-02-23 |
| 2014-09-30 | $23.40M 10-Q · filed 2015-11-06 | $46.22M derived: sum of 2 quarters · filed 2015-11-06 | $64.30M 10-Q · filed 2015-11-06 | $79.89M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $22.82M 10-Q · filed 2015-08-06 | $40.90M 10-Q · filed 2015-08-06 | $56.49M derived: sum of 3 quarters · filed 2016-02-25 | $73.33M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $18.08M 10-Q · filed 2015-05-07 | $33.67M derived: sum of 2 quarters · filed 2016-02-25 | $50.52M derived: sum of 3 quarters · filed 2016-02-25 | $70.28M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $15.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $32.44M derived: sum of 2 quarters · filed 2016-02-25 | $52.20M derived: sum of 3 quarters · filed 2016-02-25 | $66.52M 10-K · filed 2016-02-25 |
| 2013-09-30 | $16.84M 10-Q · filed 2014-11-06 | $36.61M derived: sum of 2 quarters · filed 2014-11-06 | $50.92M 10-Q · filed 2014-11-06 | $66.76M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $19.77M 10-Q · filed 2014-08-06 | $34.08M 10-Q · filed 2014-08-06 | $49.92M derived: sum of 3 quarters · filed 2015-02-27 | $59.27M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $14.31M 10-Q · filed 2014-05-08 | $30.15M derived: sum of 2 quarters · filed 2015-02-27 | $39.50M derived: sum of 3 quarters · filed 2015-02-27 | $49.48M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $15.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $25.19M derived: sum of 2 quarters · filed 2015-02-27 | $35.17M derived: sum of 3 quarters · filed 2015-02-27 | $42.44M 10-K · filed 2015-02-27 |
| 2012-09-30 | $9.35M 10-Q · filed 2013-11-05 | $19.34M derived: sum of 2 quarters · filed 2013-11-05 | $26.60M 10-Q · filed 2013-11-05 | $36.87M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-06-30 | $9.98M 10-Q · filed 2013-08-06 | $17.25M 10-Q · filed 2013-08-06 | $27.52M derived: sum of 3 quarters · filed 2014-03-06 | $62.91M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-03-31 | $7.26M 10-Q · filed 2013-05-07 | $17.54M derived: sum of 2 quarters · filed 2014-03-06 | $52.93M derived: sum of 3 quarters · filed 2014-03-06 | $64.38M derived: sum of 4 quarters · filed 2014-03-06 |
| 2011-12-31 | $10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $45.67M derived: sum of 2 quarters · filed 2014-03-06 | $57.12M derived: sum of 3 quarters · filed 2014-03-06 | $66.14M 10-K · filed 2014-03-06 |
| 2011-09-30 | $35.40M 10-Q · filed 2012-11-07 | $46.85M derived: sum of 2 quarters · filed 2012-11-07 | $55.86M 10-Q · filed 2012-11-07 | $63.51M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $11.45M 10-Q · filed 2012-08-07 | $20.47M 10-Q · filed 2012-08-07 | $28.12M derived: sum of 3 quarters · filed 2013-03-18 | $30.52M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $9.02M 10-Q · filed 2012-05-08 | $16.67M derived: sum of 2 quarters · filed 2013-03-18 | $19.07M derived: sum of 3 quarters · filed 2013-03-18 | $21.85M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $10.06M derived: sum of 2 quarters · filed 2013-03-18 | $12.83M derived: sum of 3 quarters · filed 2013-03-18 | $15.01M 10-K · filed 2013-03-18 |
| 2010-09-30 | $2.40M 10-Q · filed 2011-11-09 | $5.18M derived: sum of 2 quarters · filed 2011-11-09 | $7.36M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $2.78M 10-Q/A · filed 2011-08-08 | $4.96M 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $19.05M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |